Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3425596
Max Phase: Preclinical
Molecular Formula: C41H61N11O7
Molecular Weight: 820.01
Molecule Type: Small molecule
Associated Items:
ID: ALA3425596
Max Phase: Preclinical
Molecular Formula: C41H61N11O7
Molecular Weight: 820.01
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)CCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C41H61N11O7/c1-26(2)24-31(48-34(53)20-19-27-12-5-3-6-13-27)35(54)51-32(25-28-14-7-4-8-15-28)36(55)49-29(16-9-21-46-40(42)43)38(57)52-23-11-18-33(52)37(56)50-30(39(58)59)17-10-22-47-41(44)45/h3-8,12-15,26,29-33H,9-11,16-25H2,1-2H3,(H,48,53)(H,49,55)(H,50,56)(H,51,54)(H,58,59)(H4,42,43,46)(H4,44,45,47)/t29-,30-,31-,32-,33-/m0/s1
Standard InChI Key: OKEFDOVVTKIHAZ-ZTTXAYQISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 820.01 | Molecular Weight (Monoisotopic): 819.4755 | AlogP: 0.45 | #Rotatable Bonds: 24 |
Polar Surface Area: 297.81 | Molecular Species: ZWITTERION | HBA: 8 | HBD: 11 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.94 | CX Basic pKa: 11.75 | CX LogP: -1.43 | CX LogD: -3.32 |
Aromatic Rings: 2 | Heavy Atoms: 59 | QED Weighted: 0.04 | Np Likeness Score: -0.08 |
1. Takayama K, Mori K, Sohma Y, Taketa K, Taguchi A, Yakushiji F, Minamino N, Miyazato M, Kangawa K, Hayashi Y.. (2015) Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites., 6 (3): [PMID:25815150] [10.1021/ml500494j] |
Source(1):